BACKGROUND: Left ventricular function changes in the postmenopausal state. However, there are conflicting reports about the effects of oestrogen on left ventricular diastolic function in postmenopausal women. OBJECTIVE: To evaluate the acute and chronic effects of oestradiol in physiological doses on diastolic heart function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. METHODS: A prospective, randomised, double blind, placebo controlled study was used to evaluate the effects of oestradiol in 34 hypertensive women with left ventricular dysfunction. The acute effects of a single 1 mg oral dose of oestradiol or placebo were determined after 90 minutes. The chronic effects of 1 mg oestradiol orally/day or placebo were determined after 12 weeks. Diastolic functional indices (mitral flow and pulmonary venous flow) were assessed by Doppler echocardiography. RESULTS: Though an appropriate serum concentration was achieved, no acute effect of oestradiol administration on left ventricular diastolic function was identified. After 12 weeks of treatment the following changes (mean (SD)) were identified in the oestradiol group: a decrease in isovolumic relaxation time from 127 (23) to 106 (16) ms (p < 0.001), and in the deceleration time of the mitral E wave from 260 (42) to 238 (20) ms (p < 0.05); and an increase in the E/A ratio from 0.8 (0.2) (basal) to 1.0 (0.2) after 12 weeks (p < 0.001). CONCLUSIONS:Hypertensive postmenopausal women who hadhormone replacement therapy over a period of 12 weeks had significant improvement in left ventricular diastolic function. No changes were identified following acute administration.
RCT Entities:
BACKGROUND: Left ventricular function changes in the postmenopausal state. However, there are conflicting reports about the effects of oestrogen on left ventricular diastolic function in postmenopausal women. OBJECTIVE: To evaluate the acute and chronic effects of oestradiol in physiological doses on diastolic heart function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. METHODS: A prospective, randomised, double blind, placebo controlled study was used to evaluate the effects of oestradiol in 34 hypertensivewomen with left ventricular dysfunction. The acute effects of a single 1 mg oral dose of oestradiol or placebo were determined after 90 minutes. The chronic effects of 1 mg oestradiol orally/day or placebo were determined after 12 weeks. Diastolic functional indices (mitral flow and pulmonary venous flow) were assessed by Doppler echocardiography. RESULTS: Though an appropriate serum concentration was achieved, no acute effect of oestradiol administration on left ventricular diastolic function was identified. After 12 weeks of treatment the following changes (mean (SD)) were identified in the oestradiol group: a decrease in isovolumic relaxation time from 127 (23) to 106 (16) ms (p < 0.001), and in the deceleration time of the mitral E wave from 260 (42) to 238 (20) ms (p < 0.05); and an increase in the E/A ratio from 0.8 (0.2) (basal) to 1.0 (0.2) after 12 weeks (p < 0.001). CONCLUSIONS:Hypertensive postmenopausal women who had hormone replacement therapy over a period of 12 weeks had significant improvement in left ventricular diastolic function. No changes were identified following acute administration.
Authors: N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger Journal: J Am Soc Echocardiogr Date: 1989 Sep-Oct Impact factor: 5.251
Authors: R M Steingart; M Packer; P Hamm; M E Coglianese; B Gersh; E M Geltman; J Sollano; S Katz; L Moyé; L L Basta Journal: N Engl J Med Date: 1991-07-25 Impact factor: 91.245
Authors: Kristian Wachtell; Jonathan N Bella; Jens Rokkedal; Vittorio Palmieri; Vasilios Papademetriou; Björn Dahlöf; Tapio Aalto; Eva Gerdts; Richard B Devereux Journal: Circulation Date: 2002-03-05 Impact factor: 29.690
Authors: M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens Journal: N Engl J Med Date: 1991-09-12 Impact factor: 91.245
Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene Journal: JAMA Date: 2002-07-17 Impact factor: 56.272
Authors: Giuseppe Schillaci; Leonella Pasqualini; Paolo Verdecchia; Gaetano Vaudo; Simona Marchesi; Carlo Porcellati; Giovanni de Simone; Elmo Mannarino Journal: J Am Coll Cardiol Date: 2002-06-19 Impact factor: 24.094
Authors: John T Clark; Munmun Chakraborty-Chatterjee; Milton Hamblin; J Michael Wyss; Ian H Fentie Journal: Endocrine Date: 2004-11 Impact factor: 3.633
Authors: Jewell A Jessup; Hao Wang; Lindsay M MacNamara; Tennille D Presley; Daniel B Kim-Shapiro; Lili Zhang; Alex F Chen; Leanne Groban Journal: Menopause Date: 2013-08 Impact factor: 2.953
Authors: Altemar S Paigel; Rogerio F Ribeiro; Aurelia A Fernandes; Gabriel P Targueta; Dalton V Vassallo; Ivanita Stefanon Journal: Reprod Biol Endocrinol Date: 2011-04-23 Impact factor: 5.211